Form 4: Clover Health Executive Sells Shares Under 10b5-1 Plan

Clover Health Investments Corp. executive Jamie L. Reynoso reported the sale of 2,384 shares of Class A Common Stock, executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., sold 2,384 shares of Class A Common Stock.
• The transaction occurred on July 8, 2026, with a sale price of $4.68 per share.
• This sale was conducted under a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.
• Following the transaction, Reynoso beneficially owns 2,832,598 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted under a pre-established Rule 10b5-1 plan, which is a standard practice for executives to diversify holdings or manage personal finances without implying negative insights into the company's performance.

Negatives

• An executive of Clover Health Investments, Corp. sold a portion of their stock holdings.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that insider sales under Rule 10b5-1 plans are common and are designed to provide an affirmative defense against allegations of insider trading by allowing executives to sell shares at predetermined times and prices. This filing indicates a routine transaction rather than a signal of negative sentiment.

Stakeholder Impact

• Shareholders may note the sale by an executive, but the Rule 10b5-1 plan mitigates concerns about insider trading. The impact on share price is likely minimal given the nature of the transaction.

Key Dates

Keywords

Clover Health Investments, CLOV, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Executive Compensation